As PSA is a tissue-specific, but not cancer-specific marker for the prostate, elevated levels of PSA during and after chemotherapy or radical prostatectomy indicate failure of therapy, and apparent recurrence of the disease. This evidence concerns the gene KLK3 and cancer.